• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC | Inspections
 


New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
 
Trade NameROTABLATOR(R) ROTATIONAL ANGIOPLASTY SYSTEM CONSOLE AND DYNAGLIDE(TM)FOOT PEDAL
Classification Namecatheter, coronary, atherectomy
Generic Namerotablator rotational angioplasty system
ApplicantBOSTON SCIENTIFIC CORP.
PMA NumberP900056
Supplement NumberS064
Date Received05/30/2001
Decision Date09/07/2001
Product Code
MCX[ Registered Establishments with MCX ]
Advisory Committee Cardiovascular
Supplement Typenormal 180 day track
Supplement Reason location change: manufacturer
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for the alternate manufacturing facilities located at plexus corporation, bothell, washington for the manufacture of the rotablator(r) console and dynaglide(tm) foot pedal and boston scientific scimed ivus technology center, fremont, california fo rinspection functions.
-
-